Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites. (Q44103766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Effect of sequence polymorphism and drug resistance on two HIV-1 Gag processing sites (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Ivan Torshin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

2

Irene T Weber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Anita Fehér

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Péter Bagossi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Péter Boross

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Bhuvaneshwari Mahalingam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

John M Louis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Terry D Copeland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Robert W Harrison

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

269

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

4114-4120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180988%20AND%20SRC:MED&resulttype=core&format=json

Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Kinetic properties of saquinavir-resistant mutants of human immunodeficiency virus type 1 protease and their implications in drug resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

The gag precursor contains a specific HIV-1 protease cleavage site between the NC (P7) and P1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Subsite preferences of retroviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Comparison of the substrate specificity of the human T-cell leukemia virus and human immunodeficiency virus proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Molecular mechanics calculations on HIV-1 protease with peptide substrates correlate with experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Molecular mechanics analysis of drug-resistant mutants of HIV protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Molecular surface sequence analysis of several E. coli enzymes and implications for existence of casein kinase-2 bacterial predecessor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Studies on the role of the S4 substrate binding site of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Kinetic and modeling studies of S3-S3' subsites of HIV proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Effect of substrate residues on the P2' preference of retroviral proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Molecular basis of HIV-1 protease drug resistance: structural analysis of mutant proteases complexed with cyclic urea inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Combining mutations in HIV-1 protease to understand mechanisms of resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Flap opening in HIV-1 protease simulated by 'activated' molecular dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Polymorphism of HIV type 1 gag p7/p1 and p1/p6 cleavage sites: clinical significance and implications for resistance to protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

Conformational stability and catalytic activity of HIV-1 protease are both enhanced at high salt concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X

The regulation of sequential processing of HIV-1 Gag by the viral protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03105.X